Adipocytes in subjects with impaired fasting glucose and impaired glucose tolerance are resistant to the anti-lipolytic effect of insulin

被引:53
作者
Abdul-Ghani, Muhammad A. [1 ]
Molina-Carrion, Marjorie [1 ]
Jani, Rucha [1 ]
Jenkinson, Christopher [1 ]
DeFronzo, Ralph A. [1 ]
机构
[1] Univ Texas Hlth Sci Ctr San Antonio, Diabet Div, San Antonio, TX 78229 USA
关键词
insulin resistance; free fatty acids; impaired fasting glucose; impaired glucose tolerance;
D O I
10.1007/s00592-008-0033-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) are two intermediate states in the transition from normal glucose metabolism to type 2 diabetes. Insulin clamp studies have shown that subjects with IGT have increased insulin resistance in skeletal muscle, while subjects with IFG have near normal muscle insulin sensitivity. Because of the central role of altered free fatty acid (FFA) metabolism in the pathogenesis of insulin resistance, we have examined plasma free fatty acid concentration under fasting conditions, and during OGTT in subjects with IGT and IFG. Seventy-one NGT, 70 IGT and 46 IFG subjects were studied. Fasting plasma FFA in IGT subjects was significantly greater than NGT, while subjects with IFG had similar fasting plasma FFA concentration to NGT. However, fasting plasma insulin concentration was significantly increased in IFG subjects compared to NGT while subjects with IGT had near normal fasting plasma insulin levels. The adipocyte insulin resistance index (product of fasting plasma FFA and FPI) was significantly increased in both IFG and IGT subjects compared to NGT. During the OGTT both IFG and IGT subjects suppressed their plasma FFA concentration similarly to NGT subjects, but the post-glucose loads were significantly increased in both IFG and IGT subjects. These data suggest that both subjects with IFG and IGT have increased resistance to the antilipolytic action of insulin. However, under basal conditions, fasting hyperinsulinemia in IFG subjects is sufficient to offset the adipocyte insulin resistance and maintain normal fasting plasma FFA concentration while the lack of increase in FPI in IGT subjects results in an elevated fasting plasma FFA.
引用
收藏
页码:147 / 150
页数:4
相关论文
共 17 条
[1]   Contributions of β-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose [J].
Abdul-Ghani, MA ;
Tripathy, D ;
DeFronzo, RA .
DIABETES CARE, 2006, 29 (05) :1130-1139
[2]   Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance - Results from the veterans administration genetic epidemiology study [J].
Abdul-Ghani, MA ;
Jenkinson, CP ;
Richardson, DK ;
Tripathy, D ;
DeFronzo, RA .
DIABETES, 2006, 55 (05) :1430-1435
[3]   Effect of a sustained reduction in plasma free fatty acid concentration on intramuscular long-chain fatty acyl-CoAs and insulin action in type 2 diabetic patients [J].
Bajaj, M ;
Suraamornkul, S ;
Romanelli, A ;
Cline, GW ;
Mandarino, LJ ;
Shulman, GI ;
DeFronzo, RA .
DIABETES, 2005, 54 (11) :3148-3153
[4]   Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: Peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach [J].
Bays, H ;
Mandarino, L ;
DeFronzo, RA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (02) :463-478
[5]   Dose-response effect of elevated plasma free fatty acid on insulin signaling [J].
Belfort, R ;
Mandarino, L ;
Kashyap, S ;
Wirfel, K ;
Pratipanawatr, T ;
Berria, R ;
DeFronzo, RA ;
Cusi, K .
DIABETES, 2005, 54 (06) :1640-1648
[6]   DOSE-DEPENDENT EFFECT OF INSULIN ON PLASMA-FREE FATTY-ACID TURNOVER AND OXIDATION IN HUMANS [J].
BONADONNA, RC ;
GROOP, LC ;
ZYCH, K ;
SHANK, M ;
DEFRONZO, RA .
AMERICAN JOURNAL OF PHYSIOLOGY, 1990, 259 (05) :E736-E750
[7]   FAT-METABOLISM IN HUMAN OBESITY [J].
CAMPBELL, PJ ;
CARLSON, MG ;
NURJHAN, N .
AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 266 (04) :E600-E605
[8]   Insulin resistance: A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidaemia and atherosclerosis [J].
DeFronzo, RA .
NETHERLANDS JOURNAL OF MEDICINE, 1997, 50 (05) :191-197
[9]   Pathogenesis of type 2 diabetes mellitus [J].
DeFronzo, RA .
MEDICAL CLINICS OF NORTH AMERICA, 2004, 88 (04) :787-+
[10]  
Gavin JR, 1997, DIABETES CARE, V20, P1183